Not checked for notices yet.

Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets

Pashtoon M. Kasi, Mark R. Litzow, Mrinal M. Patnaik and 2 more

Leukemia Research Reports · 2016

doi:10.1016/j.lrr.2016.01.002

Cited by papers we hold 1

FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies · 2020
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.